BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38359038)

  • 1. Bioenergetic profiles of peripheral mononuclear cells and systemic inflammation in women with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).
    Kumar P; Oster RA; Assimos DG; Ness TJ; Mitchell T
    PLoS One; 2024; 19(2):e0298981. PubMed ID: 38359038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.
    Jiang YH; Peng CH; Liu HT; Kuo HC
    PLoS One; 2013; 8(10):e76779. PubMed ID: 24146927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: Associations with painful symptoms.
    Schrepf A; O'Donnell M; Luo Y; Bradley CS; Kreder K; Lutgendorf S;
    Pain; 2014 Sep; 155(9):1755-1761. PubMed ID: 24907404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
    Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
    Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased autophagic activity of detrusor cells is involved in the inflammatory response of interstitial cystitis/bladder pain syndrome.
    Zhao J; Lu Q; Yang Z; Sun B; Zhu J; Zhang H; Yang C; Yi S; Dong X
    Int Urogynecol J; 2023 Apr; 34(4):843-851. PubMed ID: 35689690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
    Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Jiang YH; Jhang JF; Hsu YH; Kuo HC
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
    Wang L; Gao J; Zheng S; Wang Z; Zheng S; Luo Z
    Arch Esp Urol; 2024 May; 77(4):353-358. PubMed ID: 38840277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations.
    Kiuchi H; Tsujimura A; Takao T; Yamamoto K; Nakayama J; Miyagawa Y; Nonomura N; Takeyama M; Okuyama A
    BJU Int; 2009 Sep; 104(6):826-31; discussion 831. PubMed ID: 19298410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and recent exposure to adversity, TLR-4 stimulated inflammation, and diurnal cortisol in women with interstitial cystitis/bladder pain syndrome: A MAPP research network study.
    Lutgendorf SK; Zia S; Luo Y; O'Donnell M; van Bokhoven A; Bradley CS; Gallup R; Pierce J; Taple BJ; Naliboff BD; Quentin Clemens J; Kreder KJ; Schrepf A
    Brain Behav Immun; 2023 Jul; 111():116-123. PubMed ID: 37001828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
    Jiang YH; Jhang JF; Kuo HC
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of microRNA-132 attenuates inflammatory response and detrusor fibrosis in rats with interstitial cystitis via the JAK-STAT signaling pathway.
    Song YJ; Cao JY; Jin Z; Hu WG; Wu RH; Tian LH; Yang B; Wang J; Xiao Y; Huang CB
    J Cell Biochem; 2019 Jun; 120(6):9147-9158. PubMed ID: 30582204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.
    Cui X; Jing X; Lutgendorf SK; Bradley CS; Schrepf A; Erickson BA; Magnotta VA; Ness TJ; Kreder KJ; O'Donnell MA; Luo Y
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F90-F98. PubMed ID: 31091120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 and comorbid pain in Interstitial Cystitis/Bladder Pain Syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study.
    Schrepf A; Bradley CS; O'Donnell M; Luo Y; Harte SE; Kreder K; Lutgendorf S;
    Brain Behav Immun; 2015 Oct; 49():66-74. PubMed ID: 25771510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis.
    Zhao J; Wang L; Dong X; Hu X; Zhou L; Liu Q; Song B; Wu Q; Li L
    Sci Rep; 2016 Feb; 6():19670. PubMed ID: 26883396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary IL-33 and galectin-3 increase in patients with interstitial cystitis/bladder pain syndrome (review).
    Kochiashvili G; Kochiashvili D
    Georgian Med News; 2014; (232-233):12-5. PubMed ID: 25214264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell profiles of patients with interstitial cystitis/bladder pain syndrome.
    Moldwin RM; Nursey V; Yaskiv O; Dalvi S; Macdonald EJ; Funaro M; Zhang C; DeGouveia W; Ruzimovsky M; Rilo HR; Miller EJ; Najjar S; Tabansky I; Stern JNH
    J Transl Med; 2022 Feb; 20(1):97. PubMed ID: 35193610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-33 mast cell axis is central in LL-37 induced bladder inflammation and pain in a murine interstitial cystitis model.
    Martin Jensen M; Jia W; Schults AJ; Ye X; Prestwich GD; Oottamasathien S
    Cytokine; 2018 Oct; 110():420-427. PubMed ID: 29784508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
    Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
    Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Yu WR; Jiang YH; Jhang JF; Kuo HC
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.